How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? The costs of drug development have escalated greatly in recent years. Lack of drug solubility and permeability are two significant contributing factors to the return on investment from new drug launches reaching historical lows. Read the article with expert insights on how to address compounds with difficult physicochemical properties and unfavorable absorption characteristics early on in the development process to reduce costs and attrition rates.